Mapping the RAS Mutation Landscape in Pancreatic Cancer with K-Dense Web
K-Dense Web analyzed global RAS mutation prevalence, drug eligibility, statistics, and the clinical-trial landscape in pancreatic cancer (PDAC).
13 min read
Topic
Drug Development
6 K-Dense articles on Drug Development — research automation, benchmarks, and case studies from the K-Dense team.
Pharma Competitive Intelligence in One Session: CT-388 and the GLP-1/GIP Obesity Landscape
K-Dense Web queried 4 databases and ran 7 Python scripts to produce a 44-page competitive intelligence report on CT-388, Roche's GLP-1/GIP obesity agonist.
11 min readFrom Prompt to Phase III: Biomarker Discovery for Bispecific Antibodies in DLBCL
K-Dense Web integrated 6 databases, ranked 6 candidate biomarkers, and produced Phase III trial design recommendations for CD20xCD3 bispecifics in DLBCL.
8 min readFrom Genomics to Vaccine Strategy: Mapping the PDAC Neoantigen Landscape in a Single Session
K-Dense Web queried 6 databases, modeled KRAS structure, mapped the tumor microenvironment, and built a 36-slide iNeST strategy for PDAC neoantigen vaccines.
8 min readThe GBM Trial Paradox: 1,913 Trials, Zero Breakthrough Approvals
GBM clinical trial analysis: 1,913 trials, yet zero breakthrough approvals. Three insights explain the gap and where glioblastoma research must go next.
2 min readAccelerating Translational Research: How K-Dense is Transforming Drug Development
K-Dense is an agentic AI co-scientist platform that turns slow, sequential translational research into an integrated, insight-driven drug development engine.
12 min read
